Bilateral Sensorineural Hearing Loss after Adjuvant Treatment with Cyclophosphamide, Methotrexate, Fluorouracil and Alternative Oral Medications in a Male with Breast Cancer

Author： Marioni Gino  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.25, Iss.4, 2005-01, pp. : 277-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cancer

By Davide Radice   Alberto Redaelli  

PharmacoEconomics, Vol. 23, Iss. 1, 2005-01 ,pp. : 69-75

Adis International

Access to resources Recommend Favorite

Hydroxychloroquine: Bilateral sensorineural hearing loss in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1344, 2011-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Taxanes in the Adjuvant Treatment of Breast Cancer

By Trauth Donna   Goldstein Lori J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 2, 2003-04 ,pp. : 222-231

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Cyclophosphamide/fluorouracil/methotrexate: Folliculitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1102, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D   Sarkar Tarun   Hutcheon Andrew W  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite